Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Heska Corporation
  6. Summary
    HSKA   US42805E3062

HESKA CORPORATION

(HSKA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
218.72(c) 221.85(c) 221.01(c) 229.71(c) 228.92 Last
156 803 61 074 121 052 73 663 52 619 Volume
+6.06% +1.43% -0.38% +3.94% -0.34% Change
More quotes
Financials (USD)
Sales 2021 245 M - -
Net income 2021 1,22 M - -
Net cash position 2021 152 M - -
P/E ratio 2021 1 883x
Yield 2021 -
Sales 2022 272 M - -
Net income 2022 10,4 M - -
Net cash position 2022 173 M - -
P/E ratio 2022 235x
Yield 2022 -
Capitalization 2 395 M 2 395 M -
EV / Sales 2021 9,14x
EV / Sales 2022 8,17x
Nbr of Employees 602
Free-Float 94,3%
More Financials
Company
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and... 
More about the company
Ratings of Heska Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about HESKA CORPORATION
06/10HESKA  : AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Form 8-K)
PU
06/10HESKA CORP  : Change in Directors or Principal Officers, Financial Statements an..
AQ
06/07INSIDER TRENDS : 90-Days of Insider Buying at Heska Corp Eased Back with Share D..
MT
06/01HESKA  : 2021 Heska Investor Presentation
PU
05/25HESKA  : to Present at Upcoming Conferences in June 2021
PR
05/10HESKA  : Piper Sandler Adjusts Heska's Price Target to $240 From $220, Maintains..
MT
05/06HESKA CORP  : Change in Directors or Principal Officers, Submission of Matters t..
AQ
05/06HESKA  : Management's Discussion and Analysis of Financial Condition and Results..
AQ
05/06HESKA  : Swings to Q1 Profit, Revenue Increases
MT
05/06HESKA CORP  : Results of Operations and Financial Condition, Financial Statement..
AQ
05/06HESKA : Q1 Earnings Snapshot
AQ
05/06HESKA CORPORATION  : Reports First Quarter 2021 Results
PR
05/06HESKA  : Earnings Flash (HSKA) HESKA CORPORATION Posts Q1 EPS $0.59, vs. Street ..
MT
05/06HESKA  : Earnings Flash (HSKA) HESKA CORPORATION Reports Q1 Revenue $60.5M, vs. ..
MT
04/16HESKA  : Announces its Annual Meeting of Stockholders on May 5, 2021
PR
More news
News in other languages on HESKA CORPORATION

- No features available -

More news
Analyst Recommendations on HESKA CORPORATION
More recommendations
Chart HESKA CORPORATION
Duration : Period :
Heska Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HESKA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 220,50 $
Last Close Price 229,71 $
Spread / Highest target 4,48%
Spread / Average Target -4,01%
Spread / Lowest Target -20,8%
EPS Revisions
Managers and Directors
NameTitle
Kevin S. Wilson President, Chief Executive Officer & Director
Catherine I. Grassman Chief Financial Officer & Executive Vice President
Scott W. Humphrey Chairman
Glenn R. Frank Vice President-Research & Development
Nancy Wisnewski Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
HESKA CORPORATION57.71%2 395
ABBOTT LABORATORIES1.95%198 346
MEDTRONIC PLC6.89%168 458
STRYKER CORPORATION5.92%97 785
BECTON, DICKINSON AND COMPANY-3.98%69 869
IDEXX LABORATORIES, INC.20.87%51 527